[go: up one dir, main page]

BRPI0923171A2 - Prevenção e tratamento da diarréia causada por rotavírus. - Google Patents

Prevenção e tratamento da diarréia causada por rotavírus.

Info

Publication number
BRPI0923171A2
BRPI0923171A2 BRPI0923171-4A BRPI0923171A BRPI0923171A2 BR PI0923171 A2 BRPI0923171 A2 BR PI0923171A2 BR PI0923171 A BRPI0923171 A BR PI0923171A BR PI0923171 A2 BRPI0923171 A2 BR PI0923171A2
Authority
BR
Brazil
Prior art keywords
prevention
treatment
rotavirus diarrhea
rotavirus
diarrhea
Prior art date
Application number
BRPI0923171-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Fabrizio Carlo Arigoni
Harald Bruessow
Christoph Cavadini
Nicolas Page
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0923171A2 publication Critical patent/BRPI0923171A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0923171-4A 2008-12-19 2009-11-27 Prevenção e tratamento da diarréia causada por rotavírus. BRPI0923171A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08172263 2008-12-19
PCT/EP2009/065977 WO2010069737A1 (fr) 2008-12-19 2009-11-27 Prévention et traitement de la diarrhée à rotavirus

Publications (1)

Publication Number Publication Date
BRPI0923171A2 true BRPI0923171A2 (pt) 2015-08-11

Family

ID=40445496

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0923171-4A BRPI0923171A2 (pt) 2008-12-19 2009-11-27 Prevenção e tratamento da diarréia causada por rotavírus.

Country Status (12)

Country Link
US (1) US20120107279A1 (fr)
EP (1) EP2378890B1 (fr)
CN (1) CN102325458B (fr)
AU (1) AU2009328383A1 (fr)
BR (1) BRPI0923171A2 (fr)
CA (1) CA2746805A1 (fr)
MX (1) MX2011006701A (fr)
RU (1) RU2011129812A (fr)
SG (1) SG172094A1 (fr)
TW (1) TW201029584A (fr)
WO (1) WO2010069737A1 (fr)
ZA (1) ZA201105287B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2251020A1 (fr) * 2009-05-11 2010-11-17 Nestec S.A. Traitement haute température de courte durée qui génère des préparations microbiennes avec des profils anti-inflammatoires
EP2449890A1 (fr) * 2010-11-05 2012-05-09 Nestec S.A. Compositions de céréale en poudre comprenant des micro-organismes probiotiques sans réplication
EP2452575A1 (fr) * 2010-11-15 2012-05-16 Nestec S.A. Analyse de formule nutritionnelle personnalisée en fonction de l'âge avec des probiotiques
EP2520181A1 (fr) * 2011-05-02 2012-11-07 N.V. Nutricia Formulation fermentée pour nourrissons
RU2600877C2 (ru) * 2010-12-06 2016-10-27 Н.В. Нютрисиа Ферментированное детское питание
WO2012177556A2 (fr) 2011-06-20 2012-12-27 H.J. Heinz Company Méthodes et compositions probiotiques
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
KR20170091157A (ko) 2014-12-23 2017-08-08 4디 파마 리서치 리미티드 피린 폴리펩티드 및 면역 조정
HUE035569T2 (en) 2014-12-23 2018-05-28 4D Pharma Res Ltd Bacteroides thetaiotaomicron strain and its use in reducing inflammation
HUE045413T2 (hu) 2015-06-15 2019-12-30 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
ES2753779T3 (es) 2015-06-15 2020-04-14 4D Pharma Res Ltd Blautia stercosis y wexlerae para la utilización en el tratamiento de enfermedades inflamatorias y autoinmunes
LT3360559T (lt) 2015-06-15 2019-12-27 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN108513545B (zh) 2015-11-20 2020-11-03 4D制药研究有限公司 包含细菌菌株的组合物
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
SG11201807195VA (en) 2016-03-04 2018-09-27 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
TW201821093A (zh) 2016-07-13 2018-06-16 英商4D製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
HUE054164T2 (hu) 2017-05-22 2021-08-30 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
ES2855701T3 (es) 2017-06-14 2021-09-24 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
JP2020523326A (ja) 2017-06-14 2020-08-06 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3269890B2 (ja) * 1993-08-25 2002-04-02 株式会社ヤクルト本社 ワクチンの効果増強剤及び効果増強食品
RU2448720C2 (ru) * 2006-03-07 2012-04-27 Нестек С.А. Синбиотическая смесь
CA2689862A1 (fr) * 2006-06-09 2007-12-13 Nutravital Inc. Compositions probiotiques et leurs utilisations
WO2008153377A1 (fr) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition avec une bifidobactérie non viable et un oligosaccharide non digestible

Also Published As

Publication number Publication date
CN102325458B (zh) 2014-02-26
MX2011006701A (es) 2011-07-28
WO2010069737A1 (fr) 2010-06-24
AU2009328383A1 (en) 2011-07-07
US20120107279A1 (en) 2012-05-03
CN102325458A (zh) 2012-01-18
TW201029584A (en) 2010-08-16
RU2011129812A (ru) 2013-01-27
CA2746805A1 (fr) 2010-06-24
EP2378890B1 (fr) 2014-10-01
ZA201105287B (en) 2012-12-27
EP2378890A1 (fr) 2011-10-26
SG172094A1 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
BRPI0923171A2 (pt) Prevenção e tratamento da diarréia causada por rotavírus.
PT2240137T (pt) Aparelho para o tratamento da obesidade
BRPI1007015A2 (pt) implante auto-cortante e auto-limpante.
BRPI1008683A2 (pt) montagem de prevenção e queda.
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
BRPI0814874A2 (pt) combinação de agente antimitótico e inibidor da aurora quinase como tratamento anticâncer.
AP2012006094A0 (en) Treatment and prevention of dengue virus infections.
DK2330887T3 (da) Behandlingsindretning
BRPI1007990A2 (pt) Compostos específicos de diaril-hidantoína e diariltioidantoína.
DK3496503T3 (da) Uplink scrambling under random access
BRPI0917321A2 (pt) prevenção, tratamento e diagnóstico de infecção por p. gingivalis
BRPI0911757A2 (pt) composiÇÕes e mÉtodos para tratar distérbios digestivos.
BR112012002877A2 (pt) dilatador e conjunto.
BRPI0814941A2 (pt) Composição de tratamentode semente, e, método de tratamento de semente.
AP2011005901A0 (en) Thienopyridine derivatives for the treatment and prevention of dengue virus infections.
BRPI0911351A2 (pt) estrutura de sent, e , prótese de válvula.
BRPI1016199A2 (pt) cobertura de ferimento e kit de tratamento de ferimentos.
DK2175851T3 (da) Biofilmbehandling
BRPI1007929A2 (pt) "métodos e composições para o tratamento de neovascularização".
GB0823480D0 (en) Devices for the treatment of fluids
EP2254591A4 (fr) Inhibition et traitement de biofilms gastro-intestinaux
BRPI0811870A2 (pt) Tratamento e prevenção de influenza
BRPI0813922A2 (pt) composições de inibição de influenza e métodos.
DK2173831T3 (da) Brøndbehandling
EP2106253A4 (fr) Traitement de l'acouphène

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: C12R 1/01 (2006.01), A23L 33/135 (2016.01), A23L 3